Abstract
ObjectivePancreatic ductal adenocarcinoma (PDAC) is a disease of unmet medical need. While immunotherapy with chimeric antigen receptor T (CAR-T) cells has shown much promise in haematological malignancies, their efficacy for...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have